Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Stat Commun Infect Dis. 2020 Nov 11;12(Suppl 1):20190013. doi: 10.1515/scid-2019-0013

Table 5:

Descriptive characteristics of the study sample.

Successful patient tracing p-Value
No Yes
(n=16,354) (n=2,538)
n(%) n(%)
Gender
 Female & non-pregnanta 9,946 (60.8) 1,279 (50.4) <0.001
 Female & pregnanta 1,019 (6.2) 328 (12.9)
 Male 5,389 (33.0) 931 (36.7)
HIV status disclosed
 No 6,111 (37.4) 861 (33.9) 0.001
 Yes 10,243 (62.6) 1,677 (66.1)
Travel time to clinic
 <30′ 4,122 (25.2) 630 (24.8) 0.015
 30–59′ 5,075 (31.0) 861 (33.9)
 1–2 h 4,047 (24.7) 612 (24.1)
 2 + h 3,110 (19.0) 435 (17.1)
Level of care
 Primary 5,004 (30.6) 810 (31.9) <0.001
 Secondary 8,714 (53.3) 1,253 (49.4)
 Tertiary 2,636 (16.1) 475 (18.7)
Median (IQR) Median (IQR) p-Value
Ageb, years 36.0 (30.2, 42.9) 36.5 (30.6, 43.6) 0.007
CD4b, cells/μL 155 (84, 235) 153 (81, 229) 0.352
Months on ART 10.5 (2.9, 24.4) 10.2 (2.9, 23.3) 0.394
Outreach worker ratioc (×100) 5.0 (4.0, 5.9) 5.0 (3.6, 5.9) 0.003
a

Prior to first loss to clinic

b

At ART initiation.

c

# of outreach workers to total daily # of adult patients.